International Stem Cell Corporation Arranges $3 Million Equity Financing
OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, subject to determination by the investor that no material adverse event has occ...
Source: International Stem Cell Corporation - September 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
International Stem Cell Corporation Arranges $3 Million Equity Financing
OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, subject to determination by the investor that no material adverse event has occurred. The investor will ...
Source: International Stem Cell Corporation - September 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
International Stem Cell Corporation Arranges $3 Million Equity Financing
OCEANSIDE, Calif.–(BUSINESS WIRE)–International Stem Cell Corporation (OTCBB: ISCO - News) has entered into a subscription agreement with an accredited investor to sell three million dollars ($3,000,000) of Series C Preferred Stock at a price of $1.00 per share. The funding is to occur in three tranches. The first, for $700,000, closed August 20, 2008. The second closing for $1,300,000 is scheduled for September 23, 2008 and the final closing of $1,000,000 is scheduled for December 15, 2008, subject to determination by the investor that no material adverse event has occ...
Source: International Stem Cell Corporation - September 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
A Frank Discussion About Stem Cell Research with International Stem Cell CEO
Ken Aldrich, CEO of International Stem Cell Corporation, addresses some timely issues regarding stem cell research. To learn more about ISCO or to contact them regarding further questions, please visit their website here (Source: International Stem Cell Corporation)
Source: International Stem Cell Corporation - July 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
A Frank Discussion About Stem Cell Research with International Stem Cell CEO
Ken Aldrich, CEO of International Stem Cell Corporation, addresses some timely issues regarding stem cell research. To learn more about ISCO or to contact them regarding further questions, please visit their website here (Source: International Stem Cell Corporation)
Source: International Stem Cell Corporation - July 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
A Frank Discussion About Stem Cell Research with International Stem Cell CEO
Ken Aldrich, CEO of International Stem Cell Corporation, addresses some timely issues regarding stem cell research. To learn more about ISCO or to contact them regarding further questions, please visit their website here (Source: International Stem Cell Corporation)
Source: International Stem Cell Corporation - July 13, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine Source Type: podcasts
Kenneth Aldrich is Interviewed on WallSt.Net.
Listen to an Interview of International Stem Cell Corporations CEO and Co Founder Kenneth Aldrich on Wallst.net
http://www.wallst.net/audio/audio.asp?ticker=ISCO&id=4392 (Source: International Stem Cell Corporation)
Source: International Stem Cell Corporation - January 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: Uncategorized biotechnology science health medicine Source Type: podcasts
